Projects per year
Abstract
We demonstrated that a whole-blood androgen receptor-based multigene signature was an important prognostic tool in a cohort of metastatic castration-resistant prostate cancer (mCRPC)patients receiving contemporaneous systemic treatment. This signature may have a valuable role in upfront risk stratification and prognostication of mCRPC patients.
| Original language | English |
|---|---|
| Pages (from-to) | 63-70 |
| Number of pages | 8 |
| Journal | European Urology Focus |
| Volume | 7 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Jan 2021 |
Keywords
- Androgen receptor
- Androgen receptor splice variant
- Biomarker
- Castration-resistant prostate cancer
- Chemotherapy
- Prognosis
Projects
- 1 Finished
-
NHMRC Practitioner Fellowship
Davis, I. (Primary Chief Investigator (PCI))
NHMRC - National Health and Medical Research Council (Australia)
8/06/12 → 31/12/12
Project: Research